How much funding has Tyra raised?

Tyra has raised $306.0M in total funding, most recently a Series B round.

Where is Tyra headquartered?

Tyra is headquartered in Carlsbad, California, United States.

What industry is Tyra in?

Tyra operates in Biotech, Healthcare.

Tyra

IPO

Developing Next-Generation Precision Molecules

Carlsbad, United States · Founded 2019 · $306.0M raised

Biotech

Healthcare

Headquarters: Carlsbad, California
Employees: 51–200
Founded: 2019
Business Model: B2B

Website: tyrabio.com
Total Funding: $306.0M
Last Round: $106.0M Series B
Rounds: 2

About

Tyra Biosciences (Nasdaq: TYRA) is a clinical-stage biotechnology company developing next-generation precision medicines targeting FGFR biology to overcome acquired resistance in oncology and genetically defined conditions. The company's proprietary SNÅP platform enables rapid, iterative molecular drug design to predict and preempt genetic alterations that cause resistance to existing therapies. Its lead programs include TYRA-300, a potential first-in-class selective FGFR3 inhibitor, and TYRA-200, an FGFR1/2/3 inhibitor for intrahepatic cholangiocarcinoma.

Summary

Tyra is a Biotech company based in Carlsbad, United States, founded in 2019. It has raised $306.0M in total across 2 rounds.

X (Twitter)